2019 Antitrust in Life Sciences

October 23, 2019

Dechert LLP | Circa Centre, 2929 Arch Street, Philadelphia, PA 19104

Dechert LLP and Charles River Associates are pleased to invite you to our Antitrust in Life Sciences program.

A dynamic and explorative forum on current and developing antitrust trends, the program will feature leadership from the Federal Trade Commission, the European Commission and the State Attorneys General.

Highlights will include:

Merger review – treatment of pipeline products, the latest in brand drug and generic drug market definition, supply chain competition and divestiture policies and practices.
Life cycle management and contracting – product introduction strategies, patent settlements, alleged misuse of the regulatory process and limited or exclusive distribution.
Pricing strategies – bundled pricing and rebating strategies, narrow and preferred networks, pricing communications and government enforcement and class action trends.

Featured Speakers:

Paul Csiszár
Director Basic Industries
Manufacturing and Agriculture, DG Competition
European Commission
Gail Levine
Deputy Director
Bureau of Competition
Federal Trade Commission
Amy McFarlane
Assistant Attorney General
Antitrust Bureau
Office of the New York State Attorney General

Dechert Speakers:

Steve Bizar
Partner, Dechert
Mike Cowie
Partner, Dechert
George Gordon
Partner, Dechert
Mélanie Thill-Tayara
Partner, Dechert

CRA Speakers:

Greg Bell
Group Vice President and Life Sciences Practice Leader, Charles River Associates
Raphaël De Coninck
Vice President, Charles River Associates
Steven Tenn
Vice President, Charles River Associates